Clinical characteristics and treatment outcomes in patients with liver cirrhosis and lymphoma

Table 4 Type of chemotherapy and treatment outcomes, n (%)

Chemotherapy	Cases (n = 10)	Controls (n = 20)
Drugs
Rituximab	5 (50)	9 (45)
Cyclophosphamide	8 (80)	17 (85)
Doxorubicin	5 (50)	15 (75)
Vincristine	8 (80)	17 (85)
Prednisone	6 (60)	17 (85)
Bleomycin	2 (20)	3 (15)
Dacarbazine	1 (10)	2 (10)
Etoposide	4 (40)	3 (15)
Vinblastine	0 (0)	2 (10)
Methotrexate	1 (10)	4 (20)
Ifosfamide	2 (20)	2 (10)
Carboplatin	2 (20)	2 (10)
Dexamethasone	2 (20)	1 (5)
Others	2 (20)	4 (20)
Chemotherapy adjustment	5 (50)b	1 (5)
Radiotherapy	1 (10)	2 (10)
Treatment response
Complete response	4 (40)	10 (50)
Partial response	4 (40)	9 (45)
Stable disease	2 (20)	1 (5)
Disease progression	5 (50)	5 (25)
Relapse	2 (20)	3 (15)
Complications	8 (80)	18 (90)
Hematologic toxicity	6 (60)	18 (90)
Gastrointestinal toxicity	1 (10)	0 (0)
Renal toxicity	1 (10)	0 (0)
Infectious toxicity	1 (10)	0 (0)
Decompensating events	1 (10)	-
Death	7 (70)	8 (40)

Absolute frequencies (%). ^aP < 0.05 vs controls;

^bP < 0.01 vs controls.